A2 Biotherapeutics Closes $80 Million Series C Financing to …

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif., January 09, 2025--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to …

yahoo.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing company based in Agoura Hills, Calif. A2 Bio plans to direct the Series C …

businesswire.com

A2 Bio Highlights Progress Of Tmod

3 weeks from now

A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of its Precision Cell Therapies Using its Proprietary Tmod TM Technology Platform. AGOURA …

a2bio.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

January 09, 2025 09:02 AM Eastern Standard Time. AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first …

intelligence360.news

A2 Biotherapeutics Closes $80 Million Series C Financing To

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to …

biospace.com

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025  · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a …

pacbiztimes.com

A2 Biotherapeutics Raises $80m To Advance CAR-T Therapies For …

3 weeks from now

Jan 10, 2025  · US-based biotech company A2 Biotherapeutics (A2 Bio) has secured $80m in funding to advance its pipeline of chimeric antigen receptor (CAR)-T cell therapies for solid …

pharmaceutical-technology.com

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing ...

3 weeks from now

A2 Biotherapeutics - a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively - announced the closing of …

pulse2.com

A2 Biotherapeutics Secures $80M Series C To Advance Logic …

3 weeks from now

Jan 17, 2025  · A2 Biotherapeutics, Inc., a clinical-stage company specialising in logic-gated cell therapies, has announced the successful close of an $80 million Series C financing round. The …

pharmasource.global

A2 Biotherapeutics Raises $80M Series C Funding - Finsmes.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

finsmes.com

A2 Biotherapeutics Secures $80 Million In Series C Funding For ...

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc . successfully closes an $80 million Series C financing round, led by The Column Group and Samsara BioCapital, to advance its cell therapy …

venturecapital.com

A2 Biotherapeutics Completes $80M Series C - Vcnewsdaily.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today …

vcnewsdaily.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif. – A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor …

envzone.com

A2 Biotherapeutics Raises $80M In Series C Funding

3 weeks from now

Jan 10, 2025  · Agoura Hills, California-based A2 plans to use the Series C funding to support ongoing clinical trials of its autologous CAR T-cell therapies, A2B530 and A2B694. The firm is …

precisionmedicineonline.com

Revolutionizing Cancer Treatment: A2 Biotherapeutics Secures …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics is thrilled to announce a significant funding milestone of $80 million, a strategic investment that will expedite the company’s mission to revolutionize cancer …

leadsontrees.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

financialcontent.com

Series C - A2 Biotherapeutics - 2025-01-09 - Crunchbase

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics raised $80000000 on 2025-01-09 in Series C. Venture Capital Access Online — A2 Biotherapeutics Closes $80 Million Series C Financing to Advance …

crunchbase.com

A2 Bio Closes $80M Series C Capital Raise

3 weeks from now

Jan 17, 2025  · James Robinson, CEO of A2 Biotherapeutics. (courtesy photo) Established in 2018, Agoura Hills-based A2 Biotherapeutics is developing first-in-class logic-gated cell …

pacbiztimes.com

Founder Lodge | A2 Biotherapeutics, Inc. Raises $80,000,000 At …

3 weeks from now

Jan 10, 2025  · Series C; $80,000,000 ; A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell …

founderlodge.com

Cell Therapy Startup A2 Biotherapeutics Nets $80M Series C

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics has raised $80 million to run three experimental CAR-T programs for solid tumor cancers. ... Cell ther­a­py start­up A2 Bio­ther­a­peu­tics nets $80M Se­ries C.

endpts.com